Tuesday, February 02, 2021 11:56:29 PM
Strange lack of content on this message board? Don't get me wrong guys, I love the stories of cool cars and even cooler pianos, you gents strike me as wealthy industrialists with lifestyles most not dare dream of! It must be sooo awesome to live such extravagant lives. Actually, I find it odd you have so much time to talk about it on a meaningless and sometimes questionable public message board.
For me personally, I am still learning all about the biotechnology stocks and specifically CTSO and their global leadership position in the filtration game. I have been banned or restricted for 2 years on this board and am only allowed to formulate 1 POST per day. Why is it that me, with only $2,000 currently invested in this knows far more amount the science than any of you? I never see any meaningful discussion about science, proof of concept, publication of RCT data or any other hard data that would prove efficacy ( that's actual proven benefit of usage ) Hand picked case studies are not accepted by the scientific community when it comes to proving efficacy. Our family friend Dr Kevin told me a long time ago not to pay much attention to case studies as the medical community does not.
What is going on with the Cytosorbent XL filter to remove endotoxin? It has been removed from the product listing on the website. I wish the gang here would focus on real and proven reasons to own this stock and keep the boasting about cars and pianos for facebook and what not. What happened to the "Hemodefend" trial? It was supposed to start more than a year before the pandemic was even a thing? Why are we always jumping from one potential blockbuster treatment to another? It seems now that removing blood thinners for cardiac purposes is the real focus. Heck, when I first bought, the beads didn't even do this! Are they just such a medical wonder that we keep finding newer, bigger and better uses for the beads? I am a little confused guys, can we reset and explain what we know for certain is the reason we are all here? I still maintain we need better cytokine diagnostics to guide usage. Did you know there are about 130 different varieties of cytokines? Some are helpful some are not. In my opinion ( not to boast, but seems I am far more educated than most of you ) personalizing medicine is the key moving forward and knowing which patient to treat at what time will become very important. The other nice thing with a companion diagnostic is that you can quickly measure the effectiveness of the therapy or in this case, the filtration process. Don't be afraid to ask questions, I'll be able to answer tomorrow when I next my next meal of bread and water and my chance to make my ONE DAILY post. Is there something fishy going on here guys??
All the very best to everyone, the rich, the poor and the naive
Recent CTSO News
- CytoSorbents Announces Regulatory Approval of CytoSorb® in Taiwan • GlobeNewswire Inc. • 06/24/2024 11:00:00 AM
- CytoSorbents Announces the Launch and Immediate Availability of the PuriFi™ Blood Pump in the European Union • GlobeNewswire Inc. • 06/13/2024 11:00:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/10/2024 08:31:20 PM
- CytoSorbents to Host its 2024 Virtual Annual Stockholders Meeting • GlobeNewswire Inc. • 06/05/2024 11:00:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/22/2024 08:35:12 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/09/2024 09:23:00 PM
- CytoSorbents Reports First Quarter 2024 Results • GlobeNewswire Inc. • 05/09/2024 08:17:23 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/09/2024 08:14:53 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/06/2024 09:00:30 PM
- CytoSorbents May 6, 2024 Virtual KOL and Analyst-Investor Day: STAR-T Pivotal Trial Topline Results & Real World Experience with Antithrombotic Drug Removal in Europe • GlobeNewswire Inc. • 05/02/2024 11:00:00 AM
- CytoSorbents to Report First Quarter 2024 Operating and Financial Results • GlobeNewswire Inc. • 04/26/2024 11:00:00 AM
- STAR-T Pivotal Trial Results to Be Featured as a Late-Breaking Presentation at the 2024 American Association for Thoracic Surgery Annual Meeting • GlobeNewswire Inc. • 04/17/2024 11:00:00 AM
- CytoSorbents to Report Fiscal 2023 Operating and Financial Results • GlobeNewswire Inc. • 03/06/2024 12:00:00 PM
- CytoSorbents to Present at the TD Cowen 44th Annual Health Care Conference • GlobeNewswire Inc. • 02/08/2024 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/17/2024 10:20:45 PM
- Groundbreaking Randomized Controlled Trial Reports Excellent Clinical Outcomes Using CytoSorb® Intraoperatively in Heart Transplant Patients • GlobeNewswire Inc. • 01/17/2024 12:15:00 PM
- Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 01/08/2024 08:00:03 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/28/2023 09:49:02 PM
- CytoSorbents Provides Update on the STAR-T Trial and Reports Final Independent Data and Safety Monitoring Board Recommendation • GlobeNewswire Inc. • 12/28/2023 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/15/2023 09:35:14 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/15/2023 09:34:16 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/15/2023 09:34:14 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/15/2023 09:33:21 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/15/2023 09:32:55 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/15/2023 09:32:14 PM
FEATURED POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • Jun 26, 2024 10:09 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM
North Bay Resources Announces Successful Flotation Cell Test at Bishop Gold Mill, Inyo County, California • NBRI • Jun 27, 2024 9:00 AM
Branded Legacy, Inc. and Hemp Emu Announce Strategic Partnership to Enhance CBD Product Manufacturing • BLEG • Jun 27, 2024 8:30 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM
Bantec's Howco Short Term Department of Defense Contract Wins Will Exceed $1,100,000 for the current Quarter • BANT • Jun 25, 2024 10:00 AM